A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy.

@article{Perros2005APS,
  title={A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy.},
  author={P Perros and Pat Kendall-Taylor and Chris Neoh and Sarah Frewin and Jane Dickinson},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2005},
  volume={90 9},
  pages={5321-3}
}
CONTEXT Radioiodine is an effective and safe treatment for hyperthyroidism but has been implicated as a risk factor for deterioration or new presentation of Graves' ophthalmopathy (GO). Prophylactic glucocorticoids appear to prevent this effect. OBJECTIVE The objective of this study was to document the course of GO after radioiodine therapy. DESIGN This was a prospective observational study. Patients were assessed at baseline and 2, 4, 6, and 12 months after radioiodine therapy. SETTING… CONTINUE READING